Justera Health Ltd.
VTAL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.38M | 1.41M | 1.11M | 1.42M | 3.65M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.38M | 1.41M | 1.11M | 1.42M | 3.65M |
| Cost of Revenue | 490.60K | 438.10K | 357.80K | 782.40K | 2.22M |
| Gross Profit | 888.50K | 973.40K | 749.50K | 634.00K | 1.42M |
| SG&A Expenses | 3.04M | 2.57M | 2.88M | 3.18M | 2.39M |
| Depreciation & Amortization | 86.50K | 159.70K | 226.70K | 292.60K | 425.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.62M | 3.17M | 3.46M | 4.25M | 5.03M |
| Operating Income | -2.24M | -1.76M | -2.35M | -2.84M | -1.39M |
| Income Before Tax | -2.82M | -1.03M | -1.66M | -2.24M | -2.42M |
| Income Tax Expenses | -29.40K | -29.40K | -29.40K | -29.40K | -- |
| Earnings from Continuing Operations | -2.79 | -1.00 | -1.63 | -2.21 | -2.42 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.79M | -1.00M | -1.63M | -2.21M | -2.42M |
| EBIT | -2.24M | -1.76M | -2.35M | -2.84M | -1.39M |
| EBITDA | -2.18M | -1.61M | -2.13M | -2.54M | -1.02M |
| EPS Basic | -0.02 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.01 | -0.01 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 636.33M | 597.26M | 555.22M | 513.19M | 463.88M |
| Average Diluted Shares Outstanding | 636.33M | 597.26M | 555.22M | 513.19M | 463.88M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
